Dar Al Dawa Development and Investment (AMM:DADI) Dividends Received

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

AMM:DADI Dar Al Dawa Development and Investment AMM:DADI
77 GF Score
Price JOD1.13
GF Value JOD1.10
Valuation Fairly Valued
! 4 Warning Signs
View Full Analysis

What is Dar Al Dawa Development and Investment Dividends Received?

Dividends Received only applicable to companies reporting Cash Flow from Operations in direct method.

AMM:DADI
77GF Score
Dar Al Dawa Development and Investment AMM:DADI
Dividends Received is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Dar Al Dawa Development and Investment (AMM:DADI) Overvalued in 2026?

Based on GuruFocus' analysis, Dar Al Dawa Development and Investment stock appears to be overvalued. The current stock price of JOD1.13 is trading 2.7% above its estimated GF Value™ of JOD1.10. GuruFocus considers Dar Al Dawa Development and Investment to be Fairly Valued.

Key valuation signals for AMM:DADI:

  • Dividends Received:
  • GF Value™: JOD1.10 vs. price of JOD1.13 (2.7% above fair value)
  • GF Score™: 77/100 with 4 warning signs

No single metric tells the full story. See the AMM:DADI stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Dar Al Dawa Development and Investment Business Description

Address Naour, P.O. Box 9364, Amman, JOR, 11191
Dar Al Dawa Development and Investment is a pharmaceutical company. The main objectives are the production of medical, chemical, and pharmaceutical products, and importing pharmaceutical products. The subsidiaries' main objectives are marketing and distributing the Company's products, producing some specialized medical products, and investment activities. It offers products in the therapeutic areas of anti-infective, cardiovascular, diabetes, dermatology, eye-ear preparations, gastroenterology and metabolism, genitourinary system and sex hormones, musculoskeletal system, nervous system, ophthalmological/otological, and respiratory system, as well as vitamins. The company's geographical segments are Levant and Iraq, Gulf and Yemen, Africa, and Europe and Asia.
77GF Score

Get the complete analysis for AMM:DADI

Dividends Received is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

JOD1.13
Price
JOD1.10
GF Value